Jonathan Levenson

Jonathan Levenson

Company: Tiaki Therapeutics

Job title: Vice President of Translational Biology

Seminars:

Live Q&A With Your Expert Speakers 2:45 pm

Read more

day: Track A - Day 2 pm

Modern Target Identification: Exploration of the Hypotheses Around the Use of Genetics to Inform Decision Making 1:45 pm

What does it mean for a target to be genetically enabled? How should we use genetics and genomics data to identify and prioritize drug targets for therapeutic development? What is the role of preclinical tools if human genetic data are the primary driver for target selection?Read more

day: Track A - Day 2 pm

Live Q&A With Your Expert Speakers 6:30 pm

Read more

day: Track B - Day 1 pm

An Integrated Platform for Identification & Validation of Targets for Mitigation of Neuroinflammation in Neurodegenerative Diseases 6:00 pm

Exploring how our systems biology platform is used to reveal novel targets for dementias Linking human disease datasets with ex vivo / in vivo models of neuroinflammation Identifying disease biology across 5 neurodegenerative diseases How can we best validate neuroinflammatory targets identified in patients? Discovering the best translational tools and models for studying neuroinflammationRead more

day: Track B - Day 1 pm

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.